Lim Jun Hyeok, Ryu Jeong-Seon, Cho Sang Yong, Kim Hyun-Jung, Jeon Sang Hoon, Kim Jung Soo, Nam Hae-Seong, Cho Jae Hwa, Kwak Seung Min, Lee Hong Lyeol
Department of Internal Medicine, Inha University Hospital, 27, Inhang-Ro, Jung-Gu, Incheon, 22332, Republic of Korea.
Open Med (Wars). 2018 Mar 21;13:64-66. doi: 10.1515/med-2018-0009. eCollection 2018.
Small-cell lung cancer (SCLC) is a lung cancer histological subtype unusual in its favorable response to cytotoxic chemotherapy. Life-threatening manifestations at presentation are rarely reported and should be an important clinical concern. We report a case of a 63-year-old man presenting with rapid-onset refractory severe thrombocytopenia, development of massive hemoptysis, and death from respiratory failure. This case provides clinicians a reference for this unusual presentation and carries clinical implications for managing SCLC patients.
小细胞肺癌(SCLC)是肺癌的一种组织学亚型,其对细胞毒性化疗的良好反应较为罕见。就诊时出现危及生命的表现很少被报道,但应是重要的临床关注点。我们报告一例63岁男性病例,该患者出现快速进展的难治性严重血小板减少、大量咯血,并因呼吸衰竭死亡。本病例为临床医生提供了这种不寻常表现的参考,并对SCLC患者的管理具有临床意义。